Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Dades bibliogràfiques
Autor principal:	Zaman, Rubaiyat
Altres autors:	Sharmin, Sabrina
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2024
Matèries:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Accés en línia:	http://hdl.handle.net/10361/23157

Ítems similars

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
per: Mostofa, Golam
Publicat: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
per: Dey, Manashi
Publicat: (2024)

Role of epigenetics in the development of metabolic disorders: a review
per: Mita, Tanzia Mohsin
Publicat: (2024)

Role of circular RNA in neurological disease
per: Salsabil, Labiba
Publicat: (2024)

Gene editing for neurodegenerative diseases-A review
per: Sharna, Anika Islam
Publicat: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
per: Alim, Abdul
Publicat: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
per: Annee, Israt Jahan
Publicat: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
per: Afsana, Nourin
Publicat: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
per: Chowdhury, Sariya Uzrat
Publicat: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
per: Ferdous, Labiba
Publicat: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
per: Bakar, Osama Bin Abu
Publicat: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
per: Tabassum, Nadira
Publicat: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
per: Islam, Md. Irfath
Publicat: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
per: Shehab, Habibul Mohsin
Publicat: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
per: Afreen, Nuraia
Publicat: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
per: Karmaker, Swastika
Publicat: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
per: Key, Nasrin Sultana
Publicat: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
per: Tamanna, Mst. Taskia
Publicat: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
per: Tasneem, Sadia
Publicat: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
per: Ishrat, Nowshin
Publicat: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
per: Saha, Bithi Rani
Publicat: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
per: Chowdhury, Amal
Publicat: (2024)

A review on cardiovascular development and epigenetics
per: Srity, Nafisa Alam
Publicat: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
per: Hassan, Md. Muhtaz
Publicat: (2020)

Marine compounds in the treatment of Alzheimer’s disease
per: Parveen, Sanjana
Publicat: (2022)

Alzheimer's disease and marriage : an intimate account /
per: Wright, Lore K.
Publicat: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
per: Abedin, Khondokar Mezbahul
Publicat: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
per: Tasin, Md Abtahi
Publicat: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
per: Aziz, Farhin
Publicat: (2019)

Infection and communicable diseases /
per: Brettle, Raymond Patrick
Publicat: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
per: Afra, Sumaiya
Publicat: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
per: Mahee, Sadique Abdal
Publicat: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
per: Rumman, Mosarrat, et al.
Publicat: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
per: Rawshan, A. E. Maisha
Publicat: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
per: Nayeem, Abdullah Al
Publicat: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Publicat: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
per: Islam, Md. Rakibul
Publicat: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
per: Halim, Rabea
Publicat: (2022)